Manish Sabharwal on Lupin, Indian Pharma Industry & more

It examines the impact of key legislative milestones—the 1970 Indian Patents Act and the 1984 Hatch-Waxman Act—and how Indian entrepreneurship delivered mass prosperity despite severe “regulatory cholesterol” and bureaucratic hurdles.

It explores the sector’s imperative to shift from volume to value through blockbuster drug discovery, the potential of combining AI with software capabilities, and the distinction between affordable drug access and broader public healthcare challenges.

“Bravery is probably the most important virtue because it can’t be faked,” notes Manish, emphasizing how agency and courage define successful entrepreneurs.

Watch the full conversation here:Manish Sabharwal on Indian Pharma’s Future | Sandhya Mendonca #spotlightwithsandhya